Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit.
暂无分享,去创建一个
Werner Sieghart | Danni Harris | W. Sieghart | T. Delorey | Peyman Sahbaie | P. Sahbaie | S. Huck | J. Cook | Terry Clayton | James Cook | Robert F Halliwell | Roman Furtmüller | Sigismund Huck | Timothy M DeLorey | T. Clayton | D. Harris | R. Furtmüller | R. Halliwell | Peyman Sahbaie
[1] Dongmei Cheng,et al. Inhibition of CYP2B4 by 2-ethynylnaphthalene: evidence for the co-binding of substrate and inhibitor within the active site. , 2007, Archives of biochemistry and biophysics.
[2] D. Stephens,et al. An inverse agonist selective for α5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze , 2006, Psychopharmacology.
[3] C. Adkins,et al. Effect of alpha subunit on allosteric modulation of ion channel function in stably expressed human recombinant gamma-aminobutyric acid(A) receptors determined using (36)Cl ion flux. , 2001, Molecular pharmacology.
[4] R. Rubin,et al. Immunohistochemical Study of GABAAReceptor β2/3 Subunits in the Hippocampal Formation of Aged Brains with Alzheimer-Related Neuropathologic Changes , 1997, Experimental Neurology.
[5] Matthieu Hamel,et al. Journal of Medicinal Chemistry , 2010 .
[6] R. Mckernan,et al. theta, a novel gamma-aminobutyric acid type A receptor subunit. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[7] U. Rudolph,et al. GABA(A)-receptor subtypes: a new pharmacology. , 2001, Current opinion in pharmacology.
[8] R. Horowski,et al. SEVERE ANXIETY INDUCED BY FG 7142, A β-CARBOLINE LIGAND FOR BENZODIAZEPINE RECEPTORS , 1983, The Lancet.
[9] T. Liljefors,et al. Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. , 1999, Journal of medicinal chemistry.
[10] S L Shafer,et al. Unraveling the identity of benzodiazepine binding sites in rat hipppocampus and olfactory bulb. , 2000, European journal of pharmacology.
[11] Darren R. Flower,et al. Drug design : cutting edge approaches , 2002 .
[12] R. Mckernan,et al. Which GABAA-receptor subtypes really occur in the brain? , 1996, Trends in Neurosciences.
[13] Sami I. Horih. Basic Neurochemistry , 1989, Neurology.
[14] M. Fanselow,et al. Mice Lacking the β3 Subunit of the GABAA Receptor Have the Epilepsy Phenotype and Many of the Behavioral Characteristics of Angelman Syndrome , 1998, The Journal of Neuroscience.
[15] R. Bolles,et al. Naloxone and shock-elicited freezing in the rat. , 1979 .
[16] H. Kubinyi. Strategies and recent technologies in drug discovery. , 1995, Die Pharmazie.
[17] Gerhard Klebe,et al. Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries , 1999, J. Comput. Aided Mol. Des..
[18] T. Duka,et al. The effects of a benzodiazepine receptor antagonist β-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills , 1996, Psychopharmacology.
[19] Xiaohui He,et al. Pharmacophore/Receptor Models for GABAA/BzR Subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a Comprehensive Ligand-Mapping Approach , 2000 .
[20] W. Sieghart,et al. Are GABAA Receptors Containing α5 Subunits Contributing to the Sedative Properties of Benzodiazepine Site Agonists? , 2008, Neuropsychopharmacology.
[21] E. Sigel. Properties of single sodium channels translated by Xenopus oocytes after injection with messenger ribonucleic acid. , 1987, The Journal of physiology.
[22] K Abe,et al. Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats. , 1998, European journal of pharmacology.
[23] J. Benson,et al. Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes , 1999, Nature.
[24] James J. P. Stewart,et al. MOPAC: A semiempirical molecular orbital program , 1990, J. Comput. Aided Mol. Des..
[25] M. Sarter,et al. Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers , 1997, Behavioural Brain Research.
[26] M. Davies,et al. Evidence for central benzodiazepine receptor heterogeneity from behavior tests , 1994, Pharmacology Biochemistry and Behavior.
[27] S. File. Proconvulsant action of CGS 8216 , 1983, Neuroscience Letters.
[28] K. Kawasaki,et al. A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[29] R. Mckernan,et al. u, a novel g-aminobutyric acid type A receptor subunit , 1999 .
[30] M. Filizola,et al. Benzodiazepine-Induced Hyperphagia: Development and Assessment of a 3D Pharmacophore By Computational Methods , 2000, Journal of biomolecular structure & dynamics.
[31] G. Dawson,et al. 3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and Analogues: High-Affinity γ-Aminobutyric Acid-A Benzodiazepine Receptor Ligands with α2, α3, and α5-Subtype Binding Selectivity over α1 , 2004 .
[32] R. Lin,et al. Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory. , 2001, European journal of pharmacology.
[33] G. Loew,et al. Development and assessment of a 3D pharmacophore for ligand recognition of BDZR/GABAA receptors initiating the anxiolytic response. , 2000, Bioorganic & medicinal chemistry.
[34] P. Skolnick,et al. Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors. , 1996, Journal of medicinal chemistry.
[35] D. A. Bennett. Pharmacology of the pyrazolo-type compounds: Agonist, antagonist and inverse agonist actions , 1987, Physiology & Behavior.
[36] K. Koehler,et al. Development of a comprehensive pharmacophore model for the benzodiazepine receptor. , 1995, Drug design and discovery.
[37] G. Dawson,et al. L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for α5-containing GABAA receptors , 2006, Neuropharmacology.
[38] S. Martelli,et al. Rational design, synthesis and biological evaluation of thiadiazinoacridines: a new class of antitumor agents. , 2003, Bioorganic & medicinal chemistry.
[39] M. Letizia Barreca,et al. Pharmacophore Modeling as an Efficient Tool in the Discovery of Novel Noncompetitive AMPA Receptor Antagonists , 2003, J. Chem. Inf. Comput. Sci..
[40] J. Deschamps,et al. Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR/GABA(A) antagonist. , 2003, Journal of medicinal chemistry.
[41] A. Guidotti,et al. Benzodiazepines on trial: a research strategy for their rehabilitation. , 1996, Trends in pharmacological sciences.
[42] G. Dawson,et al. Modulation of Long-term Potentiation in CA1 Region of Mouse Hippocampal Brain Slices by GABAA Receptor Benzodiazepine Site Ligands , 1997, Neuropharmacology.
[43] R. Mckernan,et al. Density and pharmacology of α5 subunit-containing GABAA receptors are preserved in hippocampus of Alzheimer’s disease patients , 2000, Neuroscience.
[44] Eric A. Barnard,et al. Analysis of the Set of GABAA Receptor Genes in the Human Genome* , 2004, Journal of Biological Chemistry.
[45] R. Maynard,et al. The Pharmacological Basis of Therapeutics. 9th ed , 1997 .
[46] A. Verloop,et al. Development and Application of New Steric Substituent Parameters in Drug Design , 1976 .
[47] U. Rudolph,et al. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. , 2004, Annual review of pharmacology and toxicology.
[48] M. Vaswani,et al. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[49] C. Broka,et al. Rational design of 6-methylsulfonylindoles as selective cyclooxygenase-2 inhibitors. , 2004, Bioorganic & medicinal chemistry letters.
[50] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[51] R. Mckernan,et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor α1 subtype , 2000, Nature Neuroscience.
[52] T. Delorey,et al. Determinants of recognition of ligands binding to benzodiazepine receptor/GABA(A) receptors initiating sedation. , 2000, European journal of pharmacology.
[53] Dongmei Cheng,et al. Inhibition of CYP2B4 by the mechanism-based inhibitor 2-ethynylnaphthalene: inhibitory potential of 2EN is dependent on the size of the substrate. , 2007, Archives of biochemistry and biophysics.
[54] H. Kubinyi,et al. Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices. , 1998, Journal of medicinal chemistry.
[55] G. Dawson,et al. The proconvulsant effects of the GABAA α5 subtype-selective compound RY-080 may not be α5-mediated , 2006 .
[56] I. Izquierdo,et al. Endogenous benzodiazepine modulation of memory processes , 1990, Neuroscience & Biobehavioral Reviews.
[57] K. Vogt,et al. Trace fear conditioning involves hippocampal α5 GABAA receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[58] G. Dawson,et al. 6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A alpha5 receptor inverse agonists. , 2002, Journal of medicinal chemistry.
[59] C. Adkins,et al. Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric AcidA Receptors Determined Using36Cl Ion Flux , 2001 .
[60] M. Davies,et al. Putative benzodiazepine partial agonists demonstrate receptor heterogeneity , 1996, Pharmacology Biochemistry and Behavior.
[61] Structural Elements of the γ-Aminobutyric Acid Type A Receptor Conferring Subtype Selectivity for Benzodiazepine Site Ligands* , 1999, The Journal of Biological Chemistry.
[62] K. Fuchs,et al. Endogenous [3H]flunitrazepam binding in human embryonic kidney cell line 293. , 1995, European journal of pharmacology.
[63] P. Whitehouse. The cholinergic deficit in Alzheimer's disease. , 1998, The Journal of clinical psychiatry.
[64] K. Inoguchi,et al. Rational design, discovery, and synthesis of a novel series of potent growth hormone secretagogues. , 2001, Journal of medicinal chemistry.
[65] F. Helmstetter,et al. Effects of Hippocampal Injections of a Novel Ligand Selective for the α5β2γ2 Subunits of the GABA/Benzodiazepine Receptor on Pavlovian Conditioning , 2002, Neurobiology of Learning and Memory.
[66] M. Sarter,et al. Bidirectional effects of β-carbolines and benzodiazepines on cognitive processes , 1987, Brain Research Bulletin.
[67] Alexander Wlodawer,et al. Rational approach to AIDS drug design through structural biology. , 2002, Annual review of medicine.
[68] G. Pei,et al. 3D-QSAR model of flavonoids binding at benzodiazepine site in GABAA receptors. , 2001, Journal of medicinal chemistry.
[69] M. Baraldi,et al. Endozepines in recurrent stupor. , 2005, Sleep medicine reviews.
[70] J. Rossier,et al. Benzodiazepine impairs and β-carboline enhances performance in learning and memory tasks , 1986, Nature.
[71] E. Perry,et al. Convergent cholinergic activities in aging and Alzheimer's disease , 1992, Neurobiology of Aging.
[72] M. Evans,et al. Midazolam inhibits long-term potentiation through modulation of GABAA receptors , 1996, Neuropharmacology.
[73] N Collinson,et al. An Inverse Agonist Selective for α5 Subunit-Containing GABAA Receptors Enhances Cognition , 2006, Journal of Pharmacology and Experimental Therapeutics.
[74] P. Seeburg,et al. Functional Expression of GABAA Chloride Channels and Benzodiazepine Binding Sites in Baculovirus Infected Insect Cells , 1992, Bio/Technology.
[75] D. Burt,et al. GABAA receptor subtypes: from pharmacology to molecular biology , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] B. R. Sastry,et al. Benzodiazepine involvement in LTP of the GABA-ergic IPSC in rat hippocampal CA1 neurons , 2005, Brain Research.
[77] H. Möhler,et al. GABAA receptor diversity and pharmacology , 2006, Cell and Tissue Research.
[78] R. Olsen,et al. Ethanol potently and competitively inhibits binding of the alcohol antagonist Ro15-4513 to α4/6β3δ GABAA receptors , 2006 .
[79] Timothy M. DeLorey,et al. GABA and Glycine , 1999 .
[80] Gerhard Trube,et al. The effect of subunit composition of rat brain GABAA receptors on channel function , 1990, Neuron.
[81] M. Filizola,et al. Development of a 3D pharmacophore for nonspecific ligand recognition of α1, α2, α3, α5, and α6 containing gabaA/benzodiazepine receptors , 2000 .
[82] G. Dawson,et al. Identification of a Novel, Selective GABAA α5 Receptor Inverse Agonist Which Enhances Cognition , 2003 .
[83] N. Bogdanovic,et al. GABA transporters (GAT-1) in Alzheimer's disease , 1999, Journal of Neural Transmission.